Emergent Biosolutions Inc (NYSE: EBS) closed the day trading at $2.29 up 0.88% from the previous closing price of $2.27. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 1115530 shares were traded. EBS stock price reached its highest trading level at $2.4100 during the session, while it also had its lowest trading level at $2.1950.
Ratios:
For a better understanding of EBS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 0.71.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’23 when Zoon Kathryn C sold 1,830 shares for $8.35 per share. The transaction valued at 15,280 led to the insider holds 49,971 shares of the business.
Zoon Kathryn C sold 1,700 shares of EBS for $14,246 on May 25 ’23. The Director now owns 51,801 shares after completing the transaction at $8.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 119.55M and an Enterprise Value of 868.05M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.11 while its Price-to-Book (P/B) ratio in mrq is 0.18. Its current Enterprise Value per Revenue stands at 0.85 whereas that against EBITDA is -1.68.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $13.67, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 2.3056, while the 200-Day Moving Average is calculated to be 3.5754.
Shares Statistics:
Over the past 3-months, EBS traded about 3.08M shares per day on average, while over the past 10 days, EBS traded about 1.15M shares per day. A total of 52.20M shares are outstanding, with a floating share count of 50.07M. Insiders hold about 4.08% of the company’s shares, while institutions hold 78.71% stake in the company. Shares short for EBS as of Mar 15, 2024 were 4.91M with a Short Ratio of 1.59, compared to 11.54M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.41% and a Short% of Float of 15.53%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.83 for the current quarter, with a high estimate of -$0.83 and a low estimate of -$0.83, while EPS last year was -$3.17. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.63 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2 and -$2 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is $3.67, with 1 analysts recommending between $3.67 and $3.67.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for EBS’s current fiscal year. The highest revenue estimate was $1.02B, while the lowest revenue estimate was $1.02B, resulting in an average revenue estimate of $1.02B. In the same quarter a year ago, actual revenue was $1.05B, down -2.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.13B in the next fiscal year. The high estimate is $1.13B and the low estimate is $1.13B. The average revenue growth estimate for next year is up 9.90% from the average revenue estimate for this year.
